Cardiac Prosthetic Devices Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029

 Designed to support strategic planning, this report breaks down key metrics and trends across the cardiac prosthetic devices sector.

 

 What Is The Current Outlook For The Cardiac Prosthetic Devices Market?
 The cardiac prosthetic devices market size has grown rapidly in recent years. It will grow from $8.2 billion in 2024 to $9.09 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to the increasing elderly population with a higher prevalence of cardiovascular diseases, rising incidence of cardiovascular diseases, improved surgical techniques, greater awareness among patients and healthcare providers about cardiac health, and supportive government policies and funding for cardiovascular health programs.
 
 The cardiac prosthetic devices market size is expected to see rapid growth in the next few years. It will grow to $13.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to the increasing elderly population prone to cardiovascular diseases, increased spending on healthcare services and devices, favorable insurance and reimbursement scenarios, increased patient preference for advanced treatment options, and higher prevalence of lifestyle-related heart conditions. Major trends in the forecast period include the development of smaller, more efficient cardiac prosthetic devices for minimally invasive procedures, advanced biocompatible materials, integration with wearable technology, improvements in battery technology, and utilization of 3d printing technology.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=18283&type=smp
 
 What Are The Driving Factors Impacting The Cardiac Prosthetic Devices Market?
 The prevalence of cardiovascular diseases is expected to propel the growth of the cardiac prosthetic devices market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. The prevalence of cardiovascular diseases is due to unhealthy lifestyles, high rates of obesity, poor diet, lack of physical activity, high stress levels, and an aging population. Cardiac prosthetic devices play a significant role in managing cardiovascular diseases by supporting or replacing the heart’s function or its components. For instance, in January 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the prevalence of cardiovascular diseases is driving the growth of the cardiac prosthetic devices market. 
 
 Analysis Of Major Segments Driving The Cardiac Prosthetic Devices Market Growth
 The cardiac prosthetic devices market covered in this report is segmented — 
 
 1) By Type: Valves, Pacemakers 
 2) By Applications: Surgery, Research 
 3) By End User: Hospitals, Clinics Or Cardiac Centers, Ambulatory Surgical Centers, Other End-Users 
 
 Subsegments:
 1) By Valves: Mechanical Valves, Tissue Valves, Transcatheter Heart Valves 
 2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers
 
 
 What Are The Upcoming Trends Of Cardiac Prosthetic Devices Market In The Globe?
 Major companies operating in the cardiac prosthetic devices market are focused on developing innovative technologies, such as transcatheter pacing systems, to enhance cardiac function, reduce procedural invasiveness, and improve patient outcomes in managing heart rhythm disorders. A transcatheter pacing system is a minimally invasive device implanted via a catheter to regulate the heart’s electrical activity without needing external wires or surgery. For instance, in January 2022, Medtronic plc, an Ireland-based medical device company, launched the Micra AV Transcatheter Pacing System, a compact and minimally invasive device designed to address bradycardia (slow heart rate). The Micra AV TPS is designed to provide precise and reliable pacing for patients with bradycardia, incorporating advanced technology to synchronize pacing with the heart’s natural rhythm. Its compact size and internal battery contribute to a longer lifespan, while the remote monitoring capabilities enable healthcare providers to track the device’s performance and patient outcomes more effectively.
 
 Which Are The Top Players Involved In Cardiac Prosthetic Devices Market?
 Major companies operating in the cardiac prosthetic devices market are Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Terumo Corporation, Edwards Lifesciences Corporation, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Hansen Medical Inc., Abiomed Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, ATRICURE INC., CryoLife Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Venus Medtech (Hangzhou) Inc., Braile Biomedica, Kawasumi Laboratories Inc., St. Jude Medical Inc., Sorin Group, Aortic Innovations Inc., Mic Pacetronixro 
 
 View the full cardiac prosthetic devices market report here:
 https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report
 
 Which Region Drives The Most Demand In The Cardiac Prosthetic Devices Market?
 North America was the largest region in the cardiac prosthetic devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac prosthetic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company